GTHX — G1 Therapeutics Share News
0.000.00%
Last trade - 00:00- $377.22m
- $360.81m
- $82.51m
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney
U.S. STOCKS ON THE MOVE-Walt Disney, SpringWorks, Shopify
Brief: Pharmacosmos Group To Acquire G1 Therapeutics
G1 Therapeutics jumps on $405 mln buyout from Pharmacosmos
G1 Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
G1 Therapeutics' breast cancer drug fails in late-stage trial (updated)
G1 Therapeutics falls as breast cancer drug fails to meet main goal in study
G1 Therapeutics' breast cancer therapy fails late-stage trial
Brief: G1 Therapeutics Provides Update On Phase 3 Preserve 2 Trial
Brief: G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Brady Corp, Moderna, crypto shares
U.S. STOCKS ON THE MOVE-Dorian, ChargePoint Holdings, Transcat
U.S. STOCKS ON THE MOVE-Edwards Lifesciences, Petco, Williams-Sonoma
U.S. STOCKS ON THE MOVE-PDD Holdings, Analog Devices, BuzzFeed Inc
Brief: G1 Therapeutics And Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement For Lerociclib For Radioprotective Uses
G1 Therapeutics climbs on licensing deal for radioprotective drug
G1 Therapeutics Inc reports results for the quarter ended in March - Earnings Summary